Chat With Us

IRDye® 800CW 2-DG Optical Probe

Product Ordering Information

Order online or contact your local sales office.

Order online or contact your local sales office.

Order online or contact your local sales office.

To order, please contact your local distributor

Cancer cells are often characterized by a high metabolic rate exemplified by an elevated rate of glycolysis. This observation forms the basis for positron emission tomography (PET) using glucose analogues such as 18F-2-deoxy-D-glucose (18FDG) to visualize primary tumors and their metastasis. Radiolabeled 2-deoxy-D-glucose (2-DG) is generally impractical for use in small animal studies of cancer biology. Fluorophore-labeled variants of 2-deoxy-D-glucose have been used with varying degrees of success (O’Neil et al., Lloyd et al., Cheng et al.).

Frost & Sullivan Award

LI-COR is proud to accept this prestigious award from Frost & Sullivan. Learn more.

mouse 1

Figure 1. Two examples in which IRDye 800CW 2-DG Optical Probe (10 nmol) was used to detect subcutaneous A431 tumors. Probe signal is displayed in pseudo color and is merged with a grey scale white light image of the mouse.

IRDye® 800CW 2-DG is a fluorescent optical imaging agent that has been shown to be reactive with implanted tumors derived from a number of cell lines including A431, SW620, 3T3-L1, and PC3LMN4. An example is shown in Figure 1. The optical agent exhibits the expected dose response with increasing concentrations of the agent in both cell based and animal experiments. Uptake of the agent can be effectively blocked with either unlabeled 2-DG or glucose, confirming its specificity. Confocal microscopy demonstrated conclusively that IRDye® 800CW 2-DG is taken up by the cell and localized in the cytoplasm. While the exact mechanism of IRDye® 800CW 2-DG uptake is not known, there is strong evidence for the involvement of the GLUT transporter system.



Scroll to Top